Legionella Testing Market Share, Trends & Forecast by 2034

Request Methodology

Legionella Testing Market Outlook from 2024 to 2034

The legionella testing market is expected to be worth US$ 355.1 million in 2024. Diseases caused by Legionella require intensive care and hospitalization as it is considered one of the public health concerns.

The need for legionella testing is projected to rise at a promising CAGR of 9.9% through 2034. The industry is projected to surpass US$ 910 million by 2034. The rise in prevalence of Legionella-related disorders and the surge in awareness about their preventive management is anticipated to drive growth of the market.

Attributes	Details
Legionella Testing Market Value for 2024	US$ 355.1 million
Legionella Testing Market Value for 2034	US$ 910 million
Legionella Testing Market Forecast CAGR for 2024 to 2034	9.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Highlights of the Legionella Testing Industry

The legionella testing industry has validated technological advancements, certainly leading to the development of more authentic and efficient testing methods.
Boom in the availability of rapid testing kits for legionella, thus, offering on-site testing capabilities with quick results.
Symbolic increase in demand for Legionella testing services can be seen leading to growth in awareness of Legionnaires' disease and its probable impact on public health.
The Legionella testing market has accomplished significant growth globally, driven by rise in awareness of regulatory requirements and technological advancements.

Historical Performance and Future Growth of the Legionella Testing Market

Historical CAGR	12.4%
Forecast CAGR	9.9%

The historical CAGR of the Legionella testing market was 12.4%, indicating an impressive rate over the past few years. The forecast CAGR is expected to be 9.9%, indicating a steady decrease in the growth rate through 2034.

The business tests required for Legionella are focusing more on education and training as the awareness of the disease spreads.
Environmental evaluations, risk management advice, and remediation services are some of the services provided by the Legionella testing sector in addition to standard water testing.

The forecast CAGR of 9.9% indicates a decrease in the growth rate of the market in comparison to the historical CAGR in the future. The fall in CAGR can be attributed to several factors, including

Modifications in customer priorities or preferences about Legionella risk control techniques may impact the demand for testing services. For example, the demand certainly increases more slowly when certain clients prioritize investments in other areas of facility management or embrace other risk mitigation strategies.
Unpredicted occurrences, like natural catastrophes, international health emergencies, or geopolitical unrest, might alter market dynamics and impact the market growth trajectory.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Key Threats Hampering the Legionella Testing Market

Certain facilities may disregard regulatory standards because they lack the necessary resources, oversight, or knowledge of the rules, resulting in gaps required for testing and possible epidemics.
Due to the rise in financial limitations, some companies might prioritize other expenses over Legionella testing, leaving them vulnerable to outbreaks and legal repercussions.
The complexity of the testing process might be a barrier, resulting in poor or ineffective testing techniques for certain facilities, especially those with little technical experience or resources

Comparative View of the Adjacent Legionella Testing Market

This section compares the Legionella Testing industry, the clinical trial market, and the urine monitoring systems market. Clinical trials are becoming increasingly necessary as researchers determine novel therapeutic targets that create novel pharmacological molecules and investigate personalized medicine strategies, assessing the treatments safety, effectiveness, and tolerability.

The rise in incidence of chronic illnesses, including diabetes, renal disease, and urinary tract infections, act as a major factor speeding the market for urine monitoring devices.

Legionella Testing Market:

Attributes	Legionella Testing Market
CAGR from 2024 to 2034	9.9%
Opportunity	The expansion will reach emerging markets, increasing awareness of Ligionnaires' disease but limited access to testing services.
Key Trends	Surge in the continuous advancement of testing methodologies.

Clinical Trial Market:

Attributes	Clinical Trial Market
CAGR from 2024 to 2034	4.3%
Opportunity	The adoption of virtual and decentralized clinical trials is one major opportunity.
Key Trends	Research on the patient groups may result in better therapeutic outcomes and more potent treatments.

Urine Monitoring Systems Market:

Attributes	Urine Monitoring Systems Market
CAGR from 2023 to 2033	9.2%
Opportunity	Development of home-based monitoring solutions for chronic conditions like diabetes, kidney disease, and urinary tract infections.
Key Trends	Integrating Internet of Things (IoT) and Artificial Intelligence (AI) technologies.

Country-wise Insights

The table analyses the top five countries ranked by revenue, with South Korea holding the top position.

Due to government initiatives and technological advancements, South Korea is considered a prominent market. Stringent regulations and proactive measures to improve public health have spurred widespread adoption of Legionella testing in various facilities.

South Korea is a hub for technological innovation, which has led to the development of advanced testing methods and solutions. It is positioning it itself to be a leader in Legionella risk management.

The Forecast CAGRs from 2024 to 2034

Countries	CAGR
United States	10.1%
United Kingdom	11.1%
China	10.5%
Japan	11.4%
South Korea	12%

Stringent Regulatory Requirements Impresses the United States Market

The industry in the United States is heavily utilized due to stringent regulatory requirements imposed by federal and state agencies. Regulations mandate that Legionella testing be done in various facilities, such as healthcare facilities, hotels, and industrial sites, to ensure public health and safety.

High Incidence of Legionnaires Disease Drives the United Kingdom Market

Due to the relatively high incidence of Legionnaires disease, the industry is heavily utilized in the United Kingdom. The surge in awareness and proactive testing measures are taken to prevent future outbreaks in the country.

Rapid Urbanization and Industrialization Grabs Attention towards the China Market

Large-scale infrastructure projects, industrial facilities, and high-rise structures are expanding due to the growth in industrialization and urbanization of the country.

The primary purpose is to reduce the possibility of Legionella contamination in such environments, where dense populations and intricate water systems encourage bacterial growth.

Aging Infrastructure and Public Health Concerns Booms Market Growth in Japan

The aging infrastructure and burgeoning geriatric population in Japan have raised worries over public health and safety.

To ensure public health and safety, the industry widely mitigates the danger of Legionella contamination in public water systems, healthcare facilities, and older buildings.

Government Initiatives and Technological Advancements Boost South Korea Market

Government initiatives to improve public health and safety have prompted the adoption of Legionella testing measures.

The focus on technological advancements and innovation has led to the development of advanced testing methods and solutions, thus driving growth in the industry.

Category-wise Insights

The below section shows the leading segment. Based on type, the urine antigen testing (UAT) segment is registered to expand at 9.7% CAGR by 2034. Based on end-user, the clinical laboratories segment is registered to rise at 9.5% CAGR by 2034.

UAT provides quick, non-invasive results without requiring invasive procedures or specialist equipment for rapid detecteion of Legionella antigens in urine samples.

The rise in demand for diagnostic services is driven by factors such as population growth, aging demographics, and the rising prevalence of chronic diseases.

Category	CAGR from 2024 to 2034
Urine Antigen Testing (UAT)	9.7%
Clinical Laboratories	9.5%

Urine Antigen Testing (UAT) Segment to Hold a Significant Share in the Market

The urine antigen testing (UAT) segment is projected to expand at a CAGR of 9.7% by 2034, driven by its effectiveness and convenience in diagnosing ligionnaires disease.

UAT is becoming more popular as it offers rapid results and high sensitivity in detecting Legionella antigens in urine samples, where adoption is increasing, particularly in clinical settings and timely diagnosis is crucial for patient management.

Clinical Laboratories Segment to Hold a Dominant Share in the Market

Based on end-use, the clinical laboratories market expanded at 9.5% CAGR. There is a boost in demand for clinical laboratories diagnostic services, inclusive of Legionella antigen urine testing.

Clinical laboratories play a critical role in healthcare delivery by offering precise and dependable diagnostic tests, improving patient outcomes, and managing diseases.

Growth in the market is expected as urine antigen testing services are in constant demand from clinical laboratories due to the surge in frequency of Ligionnaires' disease.

Competitive Landscape

Innovative entrepreneurs have used technological breakthroughs to challenge existing players of traditional testing methods in the highly competitive market sector inside the startup ecosystem.

The firms are introducing new testing solutions, like IoT-enabled monitoring devices, AI-powered analytics platforms, and quick testing kits. By providing affordable, user-friendly, and scalable solutions, they have challenged established players and gained traction with industrial sites, healthcare facilities, and other end customers.

Startups prioritizing agility, innovation, and customer-centricity are changing the market and raising competition, certainly leading to better risk management techniques and public health results.

Key developments in the Legionella Testing industry

In May 2022, ChemREADY, launched a novel line of Legionella testing services and products for combating water-borne infections in building water systems. The move underscored the commitment to enhance public health and safety through innovative solutions.
In March 2022, IDEXX announced a significant milestone with its Legiolert test, designed to rapidly detect Legionella pneumophila. ASTM International officially recognized the test as 'ASTM D8429-21: Standard Test Method for Legionella pneumophila in Water Samples Using Legiolert'.

Key Coverage in the Legionella Testing Industry Report

Adjacent Study on Legionella Testing Market
Asia Pacific Legionella Testing Market
Legionella Testing Market Size, Current Insights, and Demographic Trends
Demand for Legionella Testing Market
Key Strategies in Global Legionella Testing Market

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 355.1 million
Projected Market Valuation in 2034	US$ 910 million
Value-based CAGR 2024 to 2034	9.9%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ million
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Market Segments Covered	Type End User Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled	Quidel Corporation Abbott (Alere) Merck KGaA Bio-Rad Laboratories Inc. Thermo Fisher Scientific Inc. Pro-lab Diagnostics Inc. bioMerieux IDEXX Corporation Eurofins Scientific Beckman Coulter Inc.

Key Segments

By Type:

Culture Media
Urine Antigen Testing (UAT)
Polymerase Chain Reaction (PCR)
Serology
Direct Fluorescent Antibody (DFA) Test

By End User:

Hospitals & Clinics
Clinical Laboratories
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

Frequently Asked Questions

What is the expected worth of the Legionella testing market in 2024?

As of 2024, the market for Legionella testing is expected to be valued at US$ 355.1 million.

What is the market potential for Legionella testing?

The Legionella testing market is projected to expand at a CAGR of 9.9 % between 2024 and 2034.

Which type of segment dominates the Legionella testing market?

The urine antigen testing (UAT) segment is projected to dominate the industry.

What is the anticipated market value for Legionella testing in 2034?

By 2034, the market value of Legionella testing is expected to reach US$ 910 million.

Which country is likely to dominate the Legionella testing market?

South Korea is likely the top-performing market, with a CAGR of 12%.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2024 to 2034

        5.3.1. Culture Media

        5.3.2. Urine Antigen Testing (UAT)

        5.3.3. Polymerase Chain Reaction (PCR)

        5.3.4. Serology

        5.3.5. Direct Fluorescent Antibody (DFA) Test

    5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2024 to 2034

        6.3.1. Hospitals & Clinics

        6.3.2. Clinical Laboratories

        6.3.3. Others

    6.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By End-User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By End-User

    8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Type

        9.2.3. By End-User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By End-User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Type

        10.2.3. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By End-User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Type

        11.2.3. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By End-User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Type

        12.2.3. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By End-User

    12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Type

        13.2.3. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By End-User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Type

        14.2.3. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By End-User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Market Share Analysis, 2023

            15.1.1.1. By Type

            15.1.1.2. By End-User

    15.2. Canada

        15.2.1. Market Share Analysis, 2023

            15.2.1.1. By Type

            15.2.1.2. By End-User

    15.3. Brazil

        15.3.1. Market Share Analysis, 2023

            15.3.1.1. By Type

            15.3.1.2. By End-User

    15.4. Mexico

        15.4.1. Market Share Analysis, 2023

            15.4.1.1. By Type

            15.4.1.2. By End-User

    15.5. Germany

        15.5.1. Market Share Analysis, 2023

            15.5.1.1. By Type

            15.5.1.2. By End-User

    15.6. UK

        15.6.1. Market Share Analysis, 2023

            15.6.1.1. By Type

            15.6.1.2. By End-User

    15.7. France

        15.7.1. Market Share Analysis, 2023

            15.7.1.1. By Type

            15.7.1.2. By End-User

    15.8. Spain

        15.8.1. Market Share Analysis, 2023

            15.8.1.1. By Type

            15.8.1.2. By End-User

    15.9. Italy

        15.9.1. Market Share Analysis, 2023

            15.9.1.1. By Type

            15.9.1.2. By End-User

    15.10. Poland

        15.10.1. Market Share Analysis, 2023

            15.10.1.1. By Type

            15.10.1.2. By End-User

    15.11. Russia

        15.11.1. Market Share Analysis, 2023

            15.11.1.1. By Type

            15.11.1.2. By End-User

    15.12. Czech Republic

        15.12.1. Market Share Analysis, 2023

            15.12.1.1. By Type

            15.12.1.2. By End-User

    15.13. Romania

        15.13.1. Market Share Analysis, 2023

            15.13.1.1. By Type

            15.13.1.2. By End-User

    15.14. India

        15.14.1. Market Share Analysis, 2023

            15.14.1.1. By Type

            15.14.1.2. By End-User

    15.15. Bangladesh

        15.15.1. Market Share Analysis, 2023

            15.15.1.1. By Type

            15.15.1.2. By End-User

    15.16. Australia

        15.16.1. Market Share Analysis, 2023

            15.16.1.1. By Type

            15.16.1.2. By End-User

    15.17. New Zealand

        15.17.1. Market Share Analysis, 2023

            15.17.1.1. By Type

            15.17.1.2. By End-User

    15.18. China

        15.18.1. Market Share Analysis, 2023

            15.18.1.1. By Type

            15.18.1.2. By End-User

    15.19. Japan

        15.19.1. Market Share Analysis, 2023

            15.19.1.1. By Type

            15.19.1.2. By End-User

    15.20. South Korea

        15.20.1. Market Share Analysis, 2023

            15.20.1.1. By Type

            15.20.1.2. By End-User

    15.21. GCC Countries

        15.21.1. Market Share Analysis, 2023

            15.21.1.1. By Type

            15.21.1.2. By End-User

    15.22. South Africa

        15.22.1. Market Share Analysis, 2023

            15.22.1.1. By Type

            15.22.1.2. By End-User

    15.23. Israel

        15.23.1. Market Share Analysis, 2023

            15.23.1.1. By Type

            15.23.1.2. By End-User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Type

        16.3.3. By End-User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Quidel Corporation

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Abbott (Alere)

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Merck KGaA

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Bio-Rad Laboratories, Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Thermo Fisher Scientific Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Pro-lab Diagnostics, Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. bioMérieux

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. IDEXX Corporation

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Eurofins Scientific

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Beckman Coulter, Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 5: North America Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 6: North America Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: Latin America Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 9: Latin America Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 11: Western Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 12: Western Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Eastern Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 15: Eastern Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: East Asia Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 21: East Asia Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End-User, 2019 to 2034

List of Charts

Figure 1: Global Market Value (US$ Million) by Type, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by End-User, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 7: Global Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 10: Global Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 13: Global Market Attractiveness by Type, 2024 to 2034

Figure 14: Global Market Attractiveness by End-User, 2024 to 2034

Figure 15: Global Market Attractiveness by Region, 2024 to 2034

Figure 16: North America Market Value (US$ Million) by Type, 2024 to 2034

Figure 17: North America Market Value (US$ Million) by End-User, 2024 to 2034

Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 22: North America Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 25: North America Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 26: North America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 27: North America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 28: North America Market Attractiveness by Type, 2024 to 2034

Figure 29: North America Market Attractiveness by End-User, 2024 to 2034

Figure 30: North America Market Attractiveness by Country, 2024 to 2034

Figure 31: Latin America Market Value (US$ Million) by Type, 2024 to 2034

Figure 32: Latin America Market Value (US$ Million) by End-User, 2024 to 2034

Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 40: Latin America Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 43: Latin America Market Attractiveness by Type, 2024 to 2034

Figure 44: Latin America Market Attractiveness by End-User, 2024 to 2034

Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 46: Western Europe Market Value (US$ Million) by Type, 2024 to 2034

Figure 47: Western Europe Market Value (US$ Million) by End-User, 2024 to 2034

Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 52: Western Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 55: Western Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 58: Western Europe Market Attractiveness by Type, 2024 to 2034

Figure 59: Western Europe Market Attractiveness by End-User, 2024 to 2034

Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 61: Eastern Europe Market Value (US$ Million) by Type, 2024 to 2034

Figure 62: Eastern Europe Market Value (US$ Million) by End-User, 2024 to 2034

Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 73: Eastern Europe Market Attractiveness by Type, 2024 to 2034

Figure 74: Eastern Europe Market Attractiveness by End-User, 2024 to 2034

Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 76: South Asia and Pacific Market Value (US$ Million) by Type, 2024 to 2034

Figure 77: South Asia and Pacific Market Value (US$ Million) by End-User, 2024 to 2034

Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 88: South Asia and Pacific Market Attractiveness by Type, 2024 to 2034

Figure 89: South Asia and Pacific Market Attractiveness by End-User, 2024 to 2034

Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 91: East Asia Market Value (US$ Million) by Type, 2024 to 2034

Figure 92: East Asia Market Value (US$ Million) by End-User, 2024 to 2034

Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 97: East Asia Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 98: East Asia Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 100: East Asia Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 101: East Asia Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 103: East Asia Market Attractiveness by Type, 2024 to 2034

Figure 104: East Asia Market Attractiveness by End-User, 2024 to 2034

Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 106: Middle East and Africa Market Value (US$ Million) by Type, 2024 to 2034

Figure 107: Middle East and Africa Market Value (US$ Million) by End-User, 2024 to 2034

Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 118: Middle East and Africa Market Attractiveness by Type, 2024 to 2034

Figure 119: Middle East and Africa Market Attractiveness by End-User, 2024 to 2034

Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

March 2024

REP-GB-19279

300 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Legionella Testing Market

Legionella Testing Market Analysis by Culture Media, Urine Antigen Testing (UAT), and Other Types from 2024 to 2034